A reversed-phase ion-interaction chromatographic method for in-vitro estimation of the percutaneous absorption of water-soluble UV filters.
An analytical method based on ion-interaction chromatography with UV detection for simultaneous in-vitro estimation of the percutaneous absorption of the most used water-soluble UV filters in sunscreen cosmetics is proposed. These UV filters were phenylbenzimidazole sulfonic acid, disodium phenyl dibenzimidazole tetrasulfonate, benzophenone-4, and terephthalylidene dicamphor sulfonic acid. The methodology is based on applying the sunscreen containing the target UV filters to human epidermis in a diffusion cell. Analytes are determined in the receptor solution. To ensure skin integrity, screening of the cells was carried out by analytical determination of a marker. Analytical variables such as percentage ethanol, concentration of ion-pairing agent, pH of the mobile phase, and temperature were studied in order to achieve high resolution of the chromatographic peaks in the lowest possible time of analysis. The conditions selected consisted of a mobile phase composed of 35:65 (v/v) ethanol-ammonium acetate buffer solution (pH 4, containing 50 mmol L(-1) tetra-n-butylammonium bromide). The chromatographic determination was carried out with the analytical column at 50 degrees C. UV detection was carried out at the maximum absorption wavelength for each analyte. The limit of detection (3s(y/x)/b) ranged from 16 to 65 ng mL(-1), depending on the analyte.
León
Z
Z
Departamento de Química Analítica, Facultad de Quimica, Universitat de València, Doctor Moliner St. 50, Burjassot, 46100, Valencia, Spain.
Balaguer
A
A
Chisvert
A
A
Salvador
A
A
Herráez
M
M
Díez
O
O
D000328:Adult; D001562:Benzimidazoles / Q000032:analysis / Q000493:pharmacokinetics; D001577:Benzophenones / Q000032:analysis / Q000493:pharmacokinetics; D001892:Camphanes / Q000032:analysis / Q000493:pharmacokinetics; D002851:Chromatography, High Pressure Liquid / Q000295:instrumentation / Q000379:methods; D004058:Diffusion; D015194:Diffusion Chambers, Culture / Q000295:instrumentation; D000078404:Epidermal Cells; D004817:Epidermis / Q000187:drug effects* / Q000378:metabolism; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007477:Ions / Q000737:chemistry; D012680:Sensitivity and Specificity; D012869:Skin Absorption / Q000187:drug effects*; D012995:Solubility; D013451:Sulfonic Acids / Q000032:analysis / Q000493:pharmacokinetics; D013473:Sunscreening Agents / Q000032:analysis* / Q000493:pharmacokinetics; D013696:Temperature; D013997:Time Factors; D014867:Water / Q000737:chemistry
D001562:Benzimidazoles; D001577:Benzophenones; D001892:Camphanes; D007477:Ions; D013451:Sulfonic Acids; D013473:Sunscreening Agents; C075352:terephthalylidene dicamphor sulfonic acid; D014867:Water; C009361:sulisobenzone; C499767:ensulizole; C503615:disodium phenyl dibenzimidazole tetrasulfonate